YCBD — cbdMD, Inc.
—
NYSE ·
Materials ·
Chemicals ·
CIK 1644903 ·
Last close
$0.76
Market Cap
$7.98M
52W High
$1.27
52W Low
$0.63
ADV30
2,589,655
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 5,640,059 | 3,256,922 | -800,784 | -797,978 | 12,252,849 | 2,638,243 | 2,968,100 |
| Dec 2025 | 5,016,904 | 3,001,294 | -286,288 | -283,131 | 11,782,124 | 3,387,933 | 2,774,158 |
| Sep 2025 | 4,720,770 | 2,777,195 | -685,816 | -679,968 | 10,419,950 | 2,261,242 | 3,193,843 |
| Jun 2025 | 4,606,796 | 2,831,087 | -904,686 | -895,272 | 9,895,256 | 1,059,559 | 3,784,753 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-1,946,890
Investing CF
$-184,587
Financing CF
$3,549,193
CapEx
$-184,587
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-3.88
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-179,759,753
Inventory
$2,979,948
Receivables
$1,117,642
ST Investments
—
EBIT TTM
$-2,362,606
Pretax Income TTM
$-2,339,128
Interest Exp TTM
—
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$19,984,530
EBITDA
$-1,638,346
Free Cash Flow
$-7,919,723
Enterprise Value
$5,766,346
Total Cash
$2,638,243
Total Debt
$415,132
Shares Out
10,497,919
Trailing EPS
$2.46
Book Value
$0.88
ROE
-53.4%
ROA
-14.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 19,190,468 | -2,162,590 | -2,040,902 | 10,419,950 | 3,193,843 | — | -1,452,375 |
| Sep 2024 | 19,482,167 | -3,315,410 | -3,700,126 | 10,581,457 | 8,618,040 | — | -352,792 |
| Sep 2023 | 24,155,362 | -9,268,549 | -22,938,209 | 16,195,283 | 7,163,999 | — | -4,302,051 |
| Sep 2022 | 35,403,224 | -17,310,545 | -70,083,693 | 40,791,909 | 9,367,478 | — | -14,967,150 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.89
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ORGN | Origin Materials, Inc. | $7.98M | $1.45 | — |
| BON | Bon Natural Life Ltd | $7.79M | $1.28 | — |
| GWTI | GREENWAY TECHNOLOGIES, INC. & SUBSIDIARIES | $7.53M | $0.02 | — |
| EVGN | Evogene Ltd. | $7.38M | $0.71 | — |
| DQWS | DSwiss Inc | $8.69M | $0.04 | — |
News headlines (Yahoo Finance, 1h cache)
cbdMD Inc (YCBD) Q2 2026 Earnings Call Highlights: Strong Sales Growth Amidst Regulatory Challenges
2026-05-15 05:03 · Yahoo
cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum
2026-05-14 20:10 · Yahoo
cbdMD, Inc. Q3 2026 Earnings Call Summary
2026-05-14 12:30 · Yahoo
cbdMD, Inc. to Host Conference Call to Discuss March 31, 2026, Second Quarter Results
2026-05-12 19:02 · Yahoo
Candy-Coated Costs: How Unvalidated Hemp Gummies Found a Back Door Into Medicare
2026-05-11 16:35 · Yahoo
cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare
2026-04-01 12:30 · Yahoo
cbdMD, Inc. Q1 2026 Earnings Call Summary
2026-02-18 13:30 · Yahoo
cbdMD Inc (YCBD) Q1 2026 Earnings Call Highlights: Strategic Acquisitions and Financial ...
2026-02-18 05:01 · Yahoo
cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026
2026-02-17 21:10 · Yahoo
cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results
2026-02-12 22:31 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.